← boothcheck

HUM vs MOH stock comparison

HUMANA INC vs MOLINA HEALTHCARE, INC., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Both prices bet on recovery from the same Medicare-and-Medicaid margin trough, and neither company has trailing earnings sturdy enough for a clean multiple: Humana's net margin sits at 0.82%, Molina's at 0.42%, rate resets and utilization having done to both what they did to the whole government-insurance complex. Scale separates the bets, $46B against $12B, and mix: Humana is Medicare Advantage with a CenterWell care arm, Molina pure Medicaid-and-marketplace. Humana pays a 0.9% dividend through the trough; Molina pays none. Debt is a matched 0.75-0.92 turns. The pair is one wager written twice, that government rates re-normalize, sized large-cap and mid-cap.

Comparison updated 2026-07-10.

HUM vs MOH: the numbers

MetricHUMMOH
Price$383.89$229.88
Market cap$46.3B$11.7B
SectorManaged CareManaged Care
StageGrowthMature
P/B2.482.87
P/S0.340.26
EV/EBITDA17.316.5
Revenue growth+13.9%+8.0%
Operating margin4.4%0.8%
Net margin0.8%0.4%
Return on equity6.1%4.6%
Return on assets2.0%1.1%
Return on invested capital5.9%2.6%
FCF yield2.8%2.1%
Dividend yield0.9%
Debt / equity0.750.92
Current ratio1.771.63
Altman Z (solvency)4.474.02
Piotroski F (quality)8 / 97 / 9
Full HUM report → Full MOH report →
Get boothcheck's read on HUM and MOH, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.